N-PORT filing recap · December 2024
What did Sound Shore Fund buy in December 2024?
Reported stock-position changes between this filing and the previous one. These are Sound Shore Fund's own holdings, not the firm's.
Stock value
$959.91M
Positions
40
Estimated turnover
61.5%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Period in review
Sound Shore Fund opened new positions in Southwest Airlines, Citigroup, Zimmer Biomet, Bristol-Myers Squibb, Baxter International, Aes, CSX, EOG Resources, Nestle, and Match Group. The fund exited Elevance Health, CVS Health, Cardinal Health, Centene, Huntington Ingalls, Kraft Heinz, Merck, Oracle, and Pfizer. It also substantially increased its stakes in NXP Semiconductors and Check Point Software, and dramatically added to Incyte. Notable trims included substantial reductions in Vistra, Kinder Morgan, General Motors, and Public Service Enterprise Group.